XML 138 R120.htm IDEA: XBRL DOCUMENT
v3.24.3

Subsequent events - Additional Information (Detail) $ in Thousands |  | 3 Months Ended | 12 Months Ended |
--- | --- | --- | --- | ---
Jul. 10, 2024 Month | Sep. 30, 2024 AUD ($) | Jun. 30, 2024 AUD ($) | Jun. 30, 2023 AUD ($) | Jun. 30, 2022 AUD ($) | Oct. 28, 2024
Cash flows from (used in) financing activities [abstract] |  |  |  |  |  |
Proceeds from issue of shares |  |  | $ 2,914 | $ 12,972 | $ 3,726 |
ADR [member] |  |  |  |  |  |
Cash flows from (used in) financing activities [abstract] |  |  |  |  |  |
Number of shares represented by one depositary receipt |  |  | 10 |  |  |
Major ordinary share transactions [member] | ADR [member] |  |  |  |  |  |
Cash flows from (used in) financing activities [abstract] |  |  |  |  |  |
Number of shares represented by one depositary receipt |  |  |  |  |  | 100
Major ordinary share transactions [member] | ATM Issue of Shares [member] |  |  |  |  |  |
Cash flows from (used in) financing activities [abstract] |  |  |  |  |  |
Proceeds from issue of shares |  | $ 5,348,262 |  |  |  |
Major ordinary share transactions [member] | Equity Line of Credit [member] |  |  |  |  |  |
Cash flows from (used in) financing activities [abstract] |  |  |  |  |  |
Proceeds from issue of ordinary shares |  | $ 816,373 |  |  |  |
Phase II/III Clinical Trial Results for Paxalisib in Glioblastoma [member] |  |  |  |  |  |
Cash flows from (used in) financing activities [abstract] |  |  |  |  |  |
Improvement in overall survival | 3 months 24 days |  |  |  |  |
Percentage increase in improvement compared to standard health care | 33.00% |  |  |  |  |
Number of patients considered for study | Month | 313 |  |  |  |  |
Median survival in months | 14 months 23 days |  |  |  |  |
Standard overall survival in months | 13 months 25 days |  |  |  |  |
Secondary analysis median survival in months | 15 months 16 days |  |  |  |  |
Secondary analysis standard overall survival in months | 11 months 27 days |  |  |  |  |

X
- References No definition available. + Details
Name: | ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of shares represented by one depositary receipt. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 112 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_NumberOfSharesRepresentedByOneDepositaryReceipt
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 7 -IssueDate 2023-01-01 -Paragraph 17 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_ProceedsFromIssueOfOrdinaryShares
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow from issuing shares. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 7 -IssueDate 2023-01-01 -Paragraph 17 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_a&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_ProceedsFromIssuingShares
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Improvement in overall survival. + References No definition available. + Details
Name: | kzia_ImprovementInOverallSurvival
Namespace Prefix: | kzia_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Median survival in months. + References No definition available. + Details
Name: | kzia_MedianSurvivalInMonths
Namespace Prefix: | kzia_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of patients considered for study. + References No definition available. + Details
Name: | kzia_NumberOfPatientsConsideredForStudy
Namespace Prefix: | kzia_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage increase in improvement compared to standard health care. + References No definition available. + Details
Name: | kzia_PercentageIncreaseInImprovementComparedToStandardHealthCare
Namespace Prefix: | kzia_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Secondary analysis median survival in months. + References No definition available. + Details
Name: | kzia_SecondaryAnalysisMedianSurvivalInMonths
Namespace Prefix: | kzia_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Secondary analysis standard overall survival in months. + References No definition available. + Details
Name: | kzia_SecondaryAnalysisStandardOverallSurvivalInMonths
Namespace Prefix: | kzia_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Standard overall survival in months. + References No definition available. + Details
Name: | kzia_StandardOverallSurvivalInMonths
Namespace Prefix: | kzia_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis=dei_AdrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_MajorOrdinaryShareTransactionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=kzia_ATMIssueOfSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | kzia_ClassesOfShareCapitalOneAxis=kzia_EquityLineOfCreditMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=kzia_PhaseTwoAndPhaseThreeClinicalTrialResultsForPaxalisibInGlioblastomaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |